Pfizer Inc.
PFE
$22.28
-$0.26-1.15%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -7.82% | 21.92% | 31.20% | 2.13% | -19.51% |
Total Other Revenue | -- | -- | -- | -- | 5.39% |
Total Revenue | -7.82% | 21.92% | 31.20% | 2.12% | -19.51% |
Cost of Revenue | -14.62% | 438.65% | -45.30% | -9.90% | -36.04% |
Gross Profit | -6.07% | -10.97% | 179.70% | 5.84% | -13.80% |
SG&A Expenses | -13.08% | 14.75% | 0.13% | 6.69% | 2.20% |
Depreciation & Amortization | -7.42% | 7.26% | 11.28% | 10.39% | 18.59% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -12.58% | 60.03% | -25.28% | 0.87% | -12.46% |
Operating Income | 2.49% | -46.04% | 344.64% | 6.71% | -31.45% |
Income Before Tax | -18.62% | 99.76% | 240.66% | -104.54% | -45.44% |
Income Tax Expenses | -164.51% | 47.04% | 124.27% | -88.73% | -59.02% |
Earnings from Continuing Operations | -4.96% | 112.33% | 287.65% | -98.68% | -43.69% |
Earnings from Discontinued Operations | -- | 126.92% | -166.67% | 950.00% | -600.00% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 25.00% | 11.11% | -33.33% | 36.36% | 38.46% |
Net Income | -4.75% | 112.17% | 287.45% | -98.24% | -43.80% |
EBIT | 2.49% | -46.04% | 344.64% | 6.71% | -31.45% |
EBITDA | -0.02% | -33.15% | 1,012.64% | 7.94% | -22.75% |
EPS Basic | -5.05% | 112.12% | 286.75% | -98.25% | -44.03% |
Normalized Basic EPS | 9.26% | -56.50% | 329.71% | -14.81% | -44.10% |
EPS Diluted | -5.30% | 111.86% | 286.75% | -98.24% | -43.40% |
Normalized Diluted EPS | 9.35% | -56.79% | 328.15% | -14.23% | -43.57% |
Average Basic Shares Outstanding | 0.32% | 0.35% | 0.37% | 0.35% | 0.41% |
Average Diluted Shares Outstanding | 0.23% | 0.99% | 1.04% | -0.30% | -0.52% |
Dividend Per Share | 2.38% | 2.44% | 2.44% | 2.44% | 2.44% |
Payout Ratio | 0.08% | 9.45% | 1.55% | 57.35% | 0.83% |